CCIA
Campbell & Co Investment Adviser’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
34,430
-23,337
| -40% | -$1.63M | 0.15% | 197 |
|
|
2025
Q1 | $4.25M | Buy |
57,767
+41,511
| +255% | +$3.05M | 0.33% | 54 |
|
|
2024
Q4 | $1.07M | Sell |
16,256
-53,334
| -77% | -$3.49M | 0.08% | 367 |
|
|
2024
Q3 | $5.42M | Buy |
+69,590
| New | +$5.42M | 0.4% | 29 |
|
|
2024
Q1 | – | Sell |
-15,296
| Closed | -$1.03M | – | 1102 |
|
|
2023
Q4 | $1.03M | Sell |
15,296
-494
| -3% | -$33.3K | 0.09% | 379 |
|
|
2023
Q3 | $1.07M | Buy |
+15,790
| New | +$1.07M | 0.13% | 244 |
|
|
2023
Q2 | – | Sell |
-13,716
| Closed | -$952K | – | 876 |
|
|
2023
Q1 | $952K | Buy |
+13,716
| New | +$952K | 0.18% | 173 |
|
|
2022
Q4 | – | Sell |
-60,459
| Closed | -$3.32M | – | 765 |
|
|
2022
Q3 | $3.32M | Buy |
+60,459
| New | +$3.32M | 0.75% | 3 |
|
|
2016
Q1 | – | Sell |
-6,200
| Closed | -$210K | – | 124 |
|
|
2015
Q4 | $210K | Buy |
+6,200
| New | +$210K | 1.4% | 44 |
|
|
2014
Q3 | – | Sell |
-49,272
| Closed | -$3.66M | – | 190 |
|
|
2014
Q2 | $3.66M | Buy |
49,272
+42,072
| +584% | +$3.13M | 1.46% | 19 |
|
|
2014
Q1 | $467K | Buy |
+7,200
| New | +$467K | 0.19% | 137 |
|